NCT02639078View on ClinicalTrials.gov

Single Ascending Dose Study of TD-0714 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Healthy
Interventions
DRUG

TD-0714

One time dosing in capsule formulation

DRUG

Placebo Comparator

One time dosing in capsule formulation

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY

NCT02639078 - Single Ascending Dose Study of TD-0714 in Healthy Subjects | Biotech Hunter | Biotech Hunter